Literature DB >> 11961074

Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action.

G Winger1, S R Hursh, K L Casey, J H Woods.   

Abstract

The potential contribution of onset and duration of pharmacological action to the reinforcing strength of three intravenously delivered N-methyl-D-aspartate antagonists was evaluated in this study. The onsets and durations of action of ketamine, phencyclidine, and dizocilpine were evaluated by observation and tabulation of their behavioral effects in rhesus monkeys after i.v. administration. The reinforcing effects of each drug were tested in a paradigm in which the fixed ratio requirements for i.v. drug injection were increased systematically. The peak observable effect of ketamine occurred immediately after its administration. There were some immediately observable effects of phencyclidine, although the peak effect of phencyclidine was delayed for 3 to 10 min. Dizocilpine had few immediate effects and a peak effect 32 min after administration. Ketamine had the shortest duration of action, followed by phencyclidine and dizocilpine. Analysis of demand curves and response output curves that were normalized to account for potency differences among the drugs revealed that ketamine and phencyclidine were equally effective as reinforcers, and they were both much stronger reinforcers than was dizocilpine. The data therefore suggest that a fast onset of action increases the reinforcing strength of drugs, although duration of action may play a role as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961074     DOI: 10.1124/jpet.301.2.690

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

1.  Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys.

Authors:  Chad M Galuska; James H Woods
Journal:  J Exp Anal Behav       Date:  2005-09       Impact factor: 2.468

2.  Tests of behavioral-economic assessments of relative reinforcer efficacy II: economic complements.

Authors:  Gregory J Madden; John R Smethells; Eric E Ewan; Steven R Hursh
Journal:  J Exp Anal Behav       Date:  2007-11       Impact factor: 2.468

3.  Tests of behavioral-economic assessments of relative reinforcer efficacy: economic substitutes.

Authors:  Gregory J Madden; John R Smethells; Eric E Ewan; Steven R Hursh
Journal:  J Exp Anal Behav       Date:  2007-03       Impact factor: 2.468

Review 4.  A review of human drug self-administration procedures.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

5.  Random-ratio schedules produce greater demand for i.v. drug administration than fixed-ratio schedules in rhesus monkeys.

Authors:  Carla H Lagorio; Gail Winger
Journal:  Psychopharmacology (Berl)       Date:  2014-02-23       Impact factor: 4.530

6.  Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.

Authors:  Joshua A Lile; Shanna Babalonis; Cleeve Emurian; Catherine A Martin; Daniel P Wermeling; Thomas H Kelly
Journal:  J Clin Pharmacol       Date:  2010-07-29       Impact factor: 3.126

Review 7.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

8.  Reinforcing effects of smoked methamphetamine in rhesus monkeys.

Authors:  Jennifer L Newman; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

Review 9.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

10.  Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats.

Authors:  Takato Hiranita; Stephen J Kohut; Paul L Soto; Gianluigi Tanda; Theresa A Kopajtic; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2013-11-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.